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ABSTRACT 2 
 3 
The number of alternative sigma factor molecules per bacterial cell determines either stochasticity or 4 
evenness of transcription of cognate promoters. An approach for examining the abundance of sigmas in 5 
any sample of bacterial origin is explained here which relies on the production of a recombinant highly 6 
specific, high-affinity single-chain variable Fv domain (scFv) targeted towards unique protein sites of the 7 
factor. Purposely, a super-binder scFv recognizing a distinct epitope of the less abundant sigma 54 of 8 
Pseudomonas putida (also known as N) was obtained and its properties examined in detail. To this end, 9 
an scFv library was generated from mRNA extracted from lymphocytes of mice immunized with the 10 
purified 54 protein of this bacterium. The library was displayed on a phage system and subjected to 11 
various rounds of panning with purified 54 for capturing extreme binders. The resulting high-affinity anti-12 
54 phage antibody (Phab) clone named C2 strongly attached a small region located between positions 13 
172 and183 of the primary amino acid sequence of 54 that overlaps its core RNA polymerase-binding 14 
region. The purified scFv-C2 detected minute amounts of 54 in whole cell protein extracts not only of P. 15 
putida but also Escherichia coli cells and putatively in other bacteria as well. The affinity constant of the 16 
purified antibody was measured by surface plasmon resonance (SPR) and found to have a KD (koff/kon) in 17 
the range of 2x10-9 M. The considerable affinity and specificity of this recombinant antibody makes it a 18 
tool of choice for quantitative studies on gene expression of 54-dependent promoters in P. putida and 19 
other Gram-negative bacteria. 20 
 21 
___________________________________________________________________________ 22 
 23 
24 
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1. Introduction 1 
 2 
The current onset of systems biology, single-cell methods and synthetic approaches has brought new 3 
perspectives to long-time recurrent questions on how the flow of gene expression from DNA to biological 4 
activity proceeds in both bacterial populations and individual cells (Swain et al., 2002). One of the most 5 
intriguing issues raised by contemporary research is that of non-homogenous transcription of given genes 6 
because of the stochastic regime that operates in the regulatory networks of single bacteria (Maier et al., 7 
2011). Stochastic phenomena in prokaryotic transcription is predicted to exacerbate when one limiting 8 
factor happens to be in short supply and its counts vary from cell to cell (Silva-Rocha and de Lorenzo, 9 
2010). Because of being at the summit of any prokaryotic gene expression program, the abundance or 10 
dearth of specific sigma factors is propagated through the entire regulatory network of bacteria in a 11 
fashion prone to create stochastic behaviour (Raffaelle et al., 2005; Ghosh et al., 2010; Silva-Rocha and 12 
de Lorenzo, 2010). There is a variety of such sigma factors that occur forming complexes with the 13 
bacterial core RNA polymerase (RNAP) and which are responsible for promoter recognition specificity 14 
(Ishihama, 2000). Most of these  factors belong to a single class that show a considerable similarity to 15 
the major, housekeeping  factor of E. coli (70; Wosten, 1998). Cognate promoters include those for 16 
expressing general maintenance functions as well as others for dealing with special conditions e.g. heat-17 
shock stress, sporulation. Sigmas of the 70-related class appear to be abundant and thus less prone to 18 
cause variations per se in gene expression among cells in a population (although other factors may 19 
become limiting in given promoters). In contrast, many eubacteria have also a separate class of  factors 20 
that is composed by a unique member (54, encoded by rpoN) that differs both in amino acid sequence 21 
and mechanism of transcription (Buck et al., 2000). Such 54 is a key element in the activation of 22 
promoters implicated in a diversity of specialized biological processes in many Gram-negative bacteria: 23 
energy metabolism, utilization of alternative nitrogen and carbon sources, expression of flagella and 24 
chemotaxis, production of secretins and several others (Reitzer and Schneider, 2001). In the genus 25 
Pseudomonas, the rpoN gene occurs in a single copy per genome and its expression seems to be 26 
constitutive and subject to negative auto-regulation (Kohler et al., 1994). Many strains of P. putida and 27 
other soil bacteria have a versatile metabolism for utilization of alternative carbon source, including 28 
aromatic compounds such as xylenes or phenols (Shingler, 2011). These biodegradative genes are often 29 
under the control of 54-dependent promoters (Carbajosa et al., 2009).  30 
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 1 
During the course of our system-level analysis of the expression of the transcriptional network that 2 
determines expression of m-xylene biodegradation in P. putida mt-2 (Koutinas et al., 2010; Silva-Rocha et 3 
al., 2011) we faced the necessity of measuring the absolute number of 54 molecules per cell. This is 4 
because the two substrate-responsive master promoters of the system, named Pu and Ps are transcribed 5 
by the 54-containing form of the RNAP in concert with a matching enhancer-binding protein called XylR 6 
(Jurado et al., 2003). The approach for tackling this issue disclosed below relies on the production of a 7 
specific recombinant antibody with an affinity for 54 which is high enough for detecting very low levels of 8 
the protein. Although the same could be in principle be brought about by a standard monoclonal derived 9 
from a hybridome (Anthony et al., 2003) we wished to exacerbate the affinity-to-be. This is feasible if one 10 
produces a large library of the hypervariable antigen-binding domain of immunoglobulins (Ig) in the format 11 
of a single-chain (scFv) molecular species and then selects for super-binders. scFvs are composed of a 12 
single polypeptide that embodies the whole binding surface which is shaped naturally by two polypeptides 13 
at the tips of the two arms of the Ig molecule. Production of scFvs requires the gene segments encoding 14 
the variable domains from the heavy (VH) and light (VL) chains of Igs (Plückthun, 1996; Winter et al., 15 
1994) to be amplified separately and then assembled in vitro as a single polypeptide chain (Fig. 1). This is 16 
made by means of a linker encoding a flexible peptide that allows cloning of the whole DNA sequence in 17 
a phagemid vector for in vivo packaging in M13 capsides and subsequent display of the scFv fused to the 18 
phage coat protein III. The angle here is that the physical association in a phage particle of the scFv 19 
antibody with its encoding gene allows the iterative enrichment of best binders (phage display; 20 
Hoogenboom, 1997). As shown below, this technique has been instrumental for isolating an scFv clone 21 
with an affinity for the 54 factor of P. putida that is high enough for detecting the very limited pool of 22 
molecules of the factor that occurs in cells of this species and other bacteria (Jishage et al., 1996). 23 
 24 
2. Materials and Methods 25 
 26 
2.1. Bacteria, phages, growth and induction conditions 27 
 28 
The E. coli strain XL-1 Blue (recA1 gyrA96 relA1 endA1 hsdR17 supE44 thi1 lac; F’proAB lacI
q
 29 
lacZ∆M15 Tn10; TcR; Stratagene) was used as the host for bacteriophages and phagemids. Alternatively, 30 
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E. coli XL-1 Blue cells were routinely grown at 30º C in 2xYT liquid media, or LB-agar plates, containing 1 
glucose (2% v/v) for repressing the lac promoter, 10 µg/ml of tetracycline (Tc) for F' selection, and 150 2 
mg/ml of ampicillin (Ap) for phagemid selection. For packaging of phagemids into M13 capsides, these E. 3 
coli cells were infected with VCS-M13 helper phage (KmR; Stratagene). Amplification of this VCS-M13 4 
helper was carried out in E. coli XL-1 Blue cells grown at 30 oC in 2xYT media containing 50 µg/ml of 5 
kanamycin (Km). The non-supressor strain E. coli HB2151 was employed for the purification of scFv C2 6 
from the periplasm. The strain harbouring the phagemid pPC2 encoding the scFv named C2 (see below) 7 
was grown in LB with ampicillin (Ap, 150 µg/ml) at 30 oC. Glucose (2% v/v) or IPTG 0.5 mM were used for 8 
repression or activation respectively of scFv C2 expression. E. coli strain BL21/DE3 (ompT hsdSB rB- mB- 9 
gal dcm lDE3; Novagen) transformed with plasmid pLysS was employed for the production of 54 10 
fragments encoded by DNA sequences cloned in pET-derivatives (Novagen). These were propagated in 11 
E. coli DH5F’ [∆(lacZYA-argF) U169 80 (lacZ∆M15) hsdR17 recA1 endA1 gyrA96 relA1 supE44 thi, 12 
F’]. E. coli BL21/DE3 and DH5F' strains were grown at 37 oC in LB media (Miller, 1992) containing 13 
appropriate antibiotics. Chloramphenicol (Cm; 30 µg/ml) and Ap (150 µg/ml) were employed for selection 14 
of pLysS and pETs, respectively. The production of 54 fragments in E. coli BL21/DE3 (pLysS) cells, 15 
harboring given pET-derivatives was induced by addition of 1.0 mM isopropyl-1-thio--D-galactoside 16 
(IPTG) to mid-log phase (OD600 ~0.5) cultures. After 2 h induction, E. coli cells were harvested from the 17 
cultures and analysed by SDS-PAGE and Western blot (see below). Pseudomonas putida strain KT2442 18 
was grown at 30 oC in LB medium. E. coli TH1 (∆lacU169, ∆rpoN) (Ow and Ausubel, 1983) and its 19 
isogenic wild type strain (E. coli  YMC9) were used as controls. 20 
 21 
2.2. Phagemids, plasmids and DNA constructs 22 
 23 
Standard methods were used to purify, analyse, manipulate, and amplify DNA (Ausubel, 1994). All 24 
oligonucleotides were synthesized by Isogen Bioscience BV. DNA constructs and phagemids were 25 
sequenced using the Dideoxy method (ABI-PRISM automated DNA sequencer, Perkin Elmer). The 26 
phagemid pCANTAB-5Ehis (ApR; Fernandez et al., 2000) was utilized for cloning and expression of the 27 
DNA sequences encoding scFv domains. The control phagemid pHen-MBP (ApR; Nissim et al., 1994) 28 
determines an scFv against the E. coli maltose binding protein (MBP). To construct the pET-vectors 29 
expressing truncated portions of 54, the DNA fragments encoding the corresponding deletions were 30 
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amplified by PCR from plasmid pNTR1, which carries the wild-type rpoN gene from P. putida in a 3.4 kb 1 
SalI fragment cloned into pUC8 (Köhler, 1990). The primer 5'-GGAAGAAGGAGATATA 2 
CCATGGCTAAACCATCGCTCGTCCTAAA-3' was employed for amplification of PCR fragments 1, 3, 4, 3 
and 5 (see below) in combination with one of the following primers: 5'-ATGATGATGTGCGGCCG 4 
CGGCGTATTGTGGGTTGA-3' for fragment 1; 5'-ATGATGATGTGCGGCCGCGCGCTTGGC 5 
TTCGGTCA-3' for fragment 3; 5'-ATGATGATGTGCGGCCGC GCAGCAACAGGCATTCG-3' for fragment 6 
4; and 5'-ATGATGATGTGCGGCCGCGGACATCGGTGCCAGGT-3' for fragment 5. For amplifying 7 
fragment 2, the primers 5'-GGAAGAAGGAGATATACCATG GAAGCCATCCCACGCCT-3' and 5'-8 
ATGATGATGTGCGGCCGCCATCAGTCGCTTGCGTT-3' were employed. The resulting DNA fragments 9 
were used as templates for a second amplification with primers T7RBS1 (5'-CCGAATTC 10 
TAATACGACTCACTATAGGGAAGAAGGAGATATA-3') and HISTAIL (5'-CGCGGATCCTCAGTGATG 11 
GTGATGATGATGTGCGGC-3') that introduced BamHI and NotI restriction sites and a polyhistidine tag 12 
(6xhis) at the extremes of the primed segments. The PCR products obtained by amplification of fragments 13 
1 and 2 were then cloned at the NcoI and BamHIII sites of pET11d (Novagen) for expression of truncated 14 
protein F1 and F2. Similarly, the DNA bearing the thereby amplified sequences 3, 4, and 5 were cloned 15 
into the NcoI and NotI pET21d (Novagen) for expression of protein fragments F3, F4, and F5. 16 
 17 
2.3. Immunizations  18 
 19 
Three female Balb/c mice were immunized by intraperitoneal (i.p.) injection with 54 of P. putida cells 20 
purified by Sepharose chromatography (Cannon et al., 1996; the kind gift of F. Bartels). To this end, the 21 
54 protein was dialysed against phosphate buffered saline (PBS; 8 mM Na2HPO4, 1.5 mM KH2PO4, 3 22 
mM KCl, 137 mM NaCl, pH 7.0) and diluted to 0.5 mg/ml in PBS containing SDS 0.1% (w/v). Just prior to 23 
injection, 0.3 ml of this protein stock were mixed with an identical volume of Ribi adjuvant (MPL+TDM™, 24 
Sigma) previously reconstituted in PBS at 1 mg/ml. 0.2 ml of this antigen/adjuvant emulsion 25 
(corresponding to 40 mg of 54) was then injected i.p. (Harlow and Lane, 1988) to each mouse at days 0, 26 
21 and 42. Ten days after the last injection, a ~100 µl blood sample was taken from each mouse, and the 27 
sera tested in ELISA (Harlow and Lane, 1988) for determining the specifc Ig response elicited against 28 
54. 29 
 30 
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2.4. Production of a scFv phage display library  1 
 2 
The protocols described by McCafferty and Johnson (1996) were followed for generation and testing of 3 
large scFv pools with the modifications specified in Fraile et al. (2001). Briefly, the spleens of inoculated 4 
mice were processed for extraction of mRNA following the guanidinium isothiocyanate-acid phenol 5 
procedure (Ultraspec™ RNA isolation, Biotecx). The poly-A+ mRNA was purified using an oligo-T resin 6 
(OligoTex™ kit, Qiagen) and then employed as template for a first-strand cDNA synthesis reaction (GE 7 
Amersham). The VH and VL gene segments were amplified from the cDNA samples using the primers 8 
indicated in (Fraile et al., 2001). The scFv-genes were then joined in a VH-linker- VH configuration. After 9 
amplification, the ~0.7 kb DNA fragments corresponding to the assembled scFvs were digested with SfiI 10 
and NotI restriction enzymes, gel-purified, and ligated into the same sites of pCANTAB-5Ehis (Fernandez 11 
et al., 2000) in such a way that the scFvs sequences become tagged with a an E-tag epitope and 12 
expressed as a fusion to the phage M13 gp3 coat (pIII) protein. The recombinant library was 13 
electroporated into E. coli XL1 Blue cells and  2x106 independent colonies were harvested from these 14 
plates in LB + glycerol (15% v/v), pooled, and stored at -80 oC. A control re-ligation of the SfiI/NotI 15 
pCANTAB-5Ehis vector used gave ~1% transformants.  16 
 17 
2.5. Rescue and selection of phagemids 18 
 19 
Assembling the library of M13 particles displaying scFv-protein III hybrids (Phab production) was done as 20 
described in (Fraile et al., 2001) and sketched in Fig. 1. For large-scale preparation of monoclonal 21 
Phab(s), a single colony of E. coli XL-1 cells harbouring the phagemid clone under examination was 22 
inoculated and the same protocol was followed. The production scFv-protein III fusions during viral 23 
packaging was tested by immunoblotting of E. coli whole-cell protein extracts (see below). For rapid 24 
screening of 54 Phab binders, a small-scale rescue of phagemids was performed in cultures of E. coli 25 
cells grown in 96-well microtitre plates and selection of those binding 54 made with the panning 26 
procedure described in (Fraile et al., 2001). To this end, purified 54 (2.5 mg/ml) was adsorbed to 27 
microtiter immunoplate (Maxisorb™, Nunc). The bound Phabs were later used to infect E. coli XL-1 Blue 28 
cells and plated on 2xYT media with glucose, Ap and Tc. After 24 h incubation at 30 oC, the resulting 29 
colonies were harvested as a pool and used for phagemid rescue. The thereby generated Phab sub-30 
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library was then subject to two additional rounds of panning for enrichment of strong 54-binders. Finally, 1 
individual Phab clones were rescued at a small scale and their specific binding to 54 determined by 2 
ELISA. 3 
 4 
2.6. Purification of the scFv C2 5 
 6 
Plasmid pPC2 was transformed into the non-suppressor E. coli strain HB2151. 250 ml of LB, containing 7 
the appropriate antibiotics were inoculated with this strain and grown at 25 oC. When the culture reached 8 
the OD600 ~1.0, IPTG was added to a final concentration of 0.5 mM, and the culture was further incubated 9 
for 16 h.  Periplasmic protein extracts were prepared following the osmotic-shock method (Harrison et al., 10 
1996) with minor modifications. For this, the E. coli cells from the overnight-induced culture were spun 11 
down and resuspended in 20 ml of a shock-buffer containing 30 mM Tris-HCl (pH 8.0), 1 mM EDTA, 20% 12 
w/v sucrose, 1 mM phenylmethyl sulfonyl fluoride (PMSF), and a cocktail of protease inhibitors 13 
(Complete™, Roche). After 20 min incubation at 4 oC, the sample was centrifuged (8000g, 15 min, 4 oC) 14 
and the supernatant (S1) separated from the sedimented biomass. This was resuspended in 20 ml of 15 
MgSO4 5 mM, and centrifuged again as above. This second supernatant (S2) was combined with S1 to 16 
obtain the periplasmic proteins extract. This fraction was dialysed against buffer DI (40 mM Tris-HCl pH 17 
8.0, 0.5 M NaCl, 5 mM MgCl2, 0.1mM PMSF). The sample was then centrifuged (6500 g, 10 min, 4 oC) to 18 
discard any particulated material and applied onto a chromatography column loaded with a Cobalt-19 
containing agarose resin (TALON™, Clontech). The matrix was washed once, first with 40 ml DI buffer 20 
and then with 20 ml DI buffer containing 5 mM imidazole pH 8.0. The bound His-tagged scFv C2 was 21 
subsequently eluted from the column by adding 15 ml of buffer DI with 100 mM imidazole at pH 8.0. 22 
Those 1 ml fractions containing the scFvs (as determined by immunoblots using anti-E-tag-MAb-POD) 23 
were pooled and dialysed against buffer DII (40 mM Tris-HCl pH 8.0, 0.15 M NaCl, 1 mM EDTA, 5 % 24 
glycerol). The concentration and purity of scFv C2 was determined by silver staining of SDS-25 
polyacrylamide gels using as standards serial 4-fold dilutions of broad range molecular weight markers 26 
(Bio-Rad). 27 
 28 
2.7. Enzyme-linked immunosorbent assays (ELISA) 29 
 30 
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ELISAs were performed at room temperature in 96-well immunoplates (Maxisorb™, Nunc) adsorbed for 2 1 
h with either 54 or ovalbumin (Sigma) suspended in 50 mM NaHCO3 pH 9.0 at a concentration of 2.5 2 
mg/ml. Excess of antigen was washed out and the plates blocked for 2 h using 200 µl per well of MBT-3 
buffer. The blocking solution was discarded and the primary antibodies (immune sera, Phabs, or purified 4 
scFvs at different concentrations) were added to the wells (50 µl of the indicated dilution in MBT-buffer). 5 
After 1 h of incubation, the unbound Igs, Phabs, or scFvs were removed by four 3-min washings of the 6 
wells with PBS, 0.1% v/v Tween 20. Detection of the bound antibodies followed a different procedure in 7 
each case: goat anti-mouse IgG-POD conjugate (Sigma) for Igs, anti-M13-MAb-POD conjugate (GE 8 
Amersham) for Phabs and anti-E-tag MAb-POD conjugate (GE Amersham) for scFvs. After 1 h incubation 9 
with these secondary antibodies (all of them at 1:5000 dilution in MBT buffer: 3% skimmed milk, 1% 10 
bovine serum albumin, and 0.1% Tween 20 in PBS), microtiter plates were washed as before and 11 
developed using a mixture (80 µl per well) of o-phenylenediamine (0.4 mg/ml; OPD, Sigma) and H2O2 12 
(0.012% v/v; Sigma) in phosphate-citrate buffer pH 5.0 (103 mM dibasic sodium phosphate, 24 mM citric 13 
acid). The reaction was then allowed to proceed in the dark for 10 min, stopped with 0.6 N HCl (20 µl of 3 14 
N HCl per well), and the OD490nm of the plates determined (Benchmark™ microplate reader, Bio-Rad). 15 
Background binding to ovoalbumin (usually OD490nm ≤ 0.05) was subtracted from the values of specific 16 
antigen-binding obtained in all cases. 17 
 18 
2.8. Protein analyses 19 
 20 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed by standard 21 
protocols using the Miniprotean™ system (Bio-Rad). Whole-cell protein extracts were prepared by 22 
harvesting the cells (10000 g, 5 min) from 1-20 ml of cultures (depending of the OD600) in LB and 23 
resuspending the pellets in 100 µl Tris HCl 10 mM pH 7.5. Next 2X SDS-sample buffer (Tris-HCl 120 mM 24 
pH 6.8, SDS 2% w/v, glycerol 10% v/v, bromophenol blue 0.01% w/v, 2-mercapto-ethanol 2% v/v) was 25 
added to the samples, boiled for 10 minutes, sonicated briefly (~5 sec) and centrifuged (14000 g, 10 min) to 26 
eliminate DNA viscosity, cell debris and other particulated material. Samples with thereby prepared extracts 27 
equivalent to ~108 cells were loaded per lane. Prestained standards (Kaleidoscope™, Bio-Rad) were used 28 
as markers of known molecular weight for the SDS-PAGE. After electrophoresis, the proteins were 29 
transferred to a polyvinylidene difluoride membrane (PVDF, Immobilon-P, Millipore) using a semi-dry 30 
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transfer apparatus (Bio-Rad). Following protein transfer, the membranes were blocked for 2 h at RT (or for 1 
16 h at 4º C) using MBT-buffer. For immunodetection of 54 with the purified recombinant antibody, 2 
membranes were incubated with 20 ml of MBT-buffer containing 500 ng of scFv C2. Unbound antibodies 3 
were eliminated by four washing steps of 5 min in 40 ml of PBS, 0.1% (v/v) Tween 20. Next, anti-E-tag-MAb-4 
POD conjugate (1:5000 in MBT-buffer, 1 mg/ml in MBT-buffer; Amersham Pharmacia Biotech) was added 5 
for detecting the bound scFvs. After 1 h incubation, the membranes were washed four times with PBS/0.1% 6 
(v/v) Tween 20, and the bound peroxidase-conjugates developed by a chemiluminiscence mixture of 1.25 7 
mM luminol (Sigma), 42 mM luciferin (Roche) and 0.0075% (v/v) H2O2 in 100 mM Tris HCl pH 8.0. BM 8 
Chemiluminiscence Blotting Substrate POD (Roche) was subsequently used for developing the peroxidase-9 
conjugates. The membranes were soaked in this mixture for 1 min in the dark and immediately exposed to 10 
an X-ray film (X-OMAT™, Kodak).  For fine-mapping of the epitope targeted by scFv C2, a collection of 11 
deca-peptides and dodeca-peptides covering residues 168 to 183 of the 54 sequence and bearing the 12 
alanine substitutions indicated in each case were synthesized by spot synthesis (Abimed, Langerfeld, 13 
Germany) onto amino-derivatized cellulose membranes (Frank and Overwin, 1996; Reusch et al., 1994). 14 
Membranes were then incubated with scFv C2 and developed with anti-E-tag-MAb-POD as explained in 15 
(Fraile et al., 2001). 16 
 17 
2.9. Affinity measurement by Biacore 18 
 19 
The affinity and kinetic parameters of binding were determined using surface plasmon resonance in a 20 
BIAcore 1000 instrument (GE Healthcare). The purified 54 antigen was covalently coupled to the 21 
carboxymethylated dextran polymer attached to a gold surface of the BIAcore sensor chip CM5 at 1547 22 
resonance units. Different concentrations (25, 50, 100, and 200 nM) of purified scFv C2 were then 23 
injected at a flow rate of 20 ml/min in buffer 50 mM Tris-HCl (pH 7.5), 50 mM KCl, 10 mM MgCl2, and 0.1 24 
mM EDTA until reaching steady state (kon).  The same buffer was injected at identical flow rate for 25 
washing bound scFvC2 (for koff determination). Binding specificity was confirmed by the injection of an 26 
unrelated scFv. The sensor chip was regenerated between the difference cycles with 20 mM glycine-HCl 27 
pH 2.5. Kinetic binding constants kon, koff, KD (koff/kon) were determined using Biacore BIA-evaluation 28 
software from the different sensograms obtained with each concentration of the analyte.  29 
 30 
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2.10. Molecular modelling 1 
 2 
The 3D simulation of the scFv C2 structure was built with the homology-modelling software SWISS-MODEL 3 
available at http://swissmodel.expasy.org/ (Arnold et al., 2006). The segment A135 to N277 of the P. putida 4 
54 protein containing the cognate target sequence was modelled using as a reference the physical 3D 5 
structure of an overlapping homologous fragment of the same sigma factor of Aquifex aeolicus (Hong et al., 6 
2009). The plausible interaction between the two proteins was visualized with the software HADDOCK 7 
http://haddock.science.uu.nl/ (de Vries et al., 2010) in which the contact surfaces were restricted to the 6 8 
CDRs (complementarity determining regions) of scFv C2 and the segment YLEDTLEEISAG of 54.   9 
 10 
3. Results and Discussion 11 
 12 
3.1. Selection of a phage antibody against 54 of P. putida 13 
 14 
A library of ~2x106 independent scFv clones was obtained from mice immunized with purified 54 of 15 
Pseudomonas putida and displayed on the capsid of M13 phages as explained in the Materials and 16 
Methods section above. These phages were employed in a panning procedure to select clones binding 17 
purified 54. Three rounds of selection and amplification of the bound phages were performed. In each 18 
round, the input phage titers were kept uniformly at 2x1011 PFU and after each selection the number of 19 
phages bound to 54 was determined. The titer of phages bound to 54 steadily increased from ~104 20 
plaque forming units (PFUs) in the first and second round to ~3 x108 PFU in the third round, indicating a 21 
selective amplification of certain phage-antibody specimens (Fig. 2A). 96 clones of the thereby amplified 22 
scFv-phage particles (Phabs) were individually rescued and their binding properties tested by ELISA. Out 23 
of this screening, 30 individual phagemid clones were found to manifest a strong and specific reactivity 24 
against purified 54. Their DNA sequence revealed that 25 of them encoded the very same scFv 25 
(hereafter referred as scFv C2, born by phagemid pPC2). Two other different scFvs clones were found 26 
among the amplified Phabs (referred as C23 and C47), but showed lower affinity for 54 in ELISA when 27 
tested individually (Fig. 2B) and were not further characterized. The amino acid sequence of scFv C2 28 
shown in Fig. 3 indicates the complementarity determining regions (CDR) of the VH and VL domains as 29 
identified with the Kabat numbering scheme (Johnson and Wu, 2001).  30 
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 1 
Note that the selection of scFv-phage particles is made under conditions where only strong binders can 2 
endure the various washings involved in the panning procedure. This is because the scFv attached to the 3 
apical pIII protein of the viral capsid represents just a minute part of the large M13 particle that is 4 
ultimately retained by the antigen (54) that coats the ELISA plate. The issues at stake are therefore [i] 5 
whether the binding of the Phabs can be traced entirely to the scFv moiety of the whole macromolecular 6 
viral complex, if so [ii] whether the binding of the isolated scFv excised from the Phab retains a high 7 
affinity for the target, [iii] what are the parameters of the interaction and [iv] how specific the scFv-54 8 
recognition is. These outstanding questions are addressed in the sections below. 9 
 10 
3.2. Binding affinity of scFv C2 for 54 11 
 12 
To study the strength of the interplay of scFv C2 with 54, the phagemid clone pPC2 encoding the 13 
antibody under examination was entered in a specialized E. coli strain which expressed the linked VH-VL 14 
fusion of the parental Phab as a single E-tagged and His-tagged polypeptide secreted into the periplasm 15 
of the host cells. This was brought about by the characteristics of the cloning vector employed for 16 
rescuing the VH-VL sequence library (pCANTAB-5Ehis; Fernandez et al., 2000) and the use of a non-17 
suppressor E. coli strain as expression host in such a way that the scFv module is produced as non-18 
fused, stand-alone polypeptide. On this basis, scFv C2 was extracted from the periplasmic protein fluid of 19 
E. coli cells transformed with pPC2 by immobilized metal-affinity chromatography as described in the 20 
Materials and Methods section. The binding properties of the purified antibody were tested in ELISA 21 
assays, where it manifested a very strong binding to purified 54 (Fig. 4A). In contrast, no significant 22 
binding to 54 was observed with a control scFv (6AC3) purified from E. coli cells by the same procedure 23 
(Fernandez et al., 2000). No detectable binding was detected either when the plates were coated with an 24 
unrelated protein e.g. ovoalbumin.  25 
 26 
To quantify the actual affinity of scFv C2 for the purified 54 of P. putida we resorted to an extraordinarily 27 
sensitive surface plasmon resonance (SPR) assay run in a BIAcore platform. To this end, the native, 28 
purified 54 factor was immobilized onto a gold surface covalently attached to carboxymethylated dextran. 29 
Preparations with various concentrations of purified scFv C2 were then injected and –after reaching an 30 
13 
 
steady state, washed with buffer only. The average data calculated from the corresponding sensograms 1 
(i.e. mean ± standard error) produced a kon (1/Ms) of 3.64 ±0,35 x105 and a koff (1/s) of 8.04 ±  0.62 x10-4, 2 
what results in an apparent dissociation constant KD (M) koff/kon = 2.29 ± 0.32 x10-9 M. Although the 3 
choice of concentrations employed in the assay was limited, these figures suggest the gross affinity of the 4 
scFv to 54 to be in the low nM range. As before, no significant signals were detected when the test was 5 
run with an unrelated scFv or when the protein immobilized on the BIAcore chip was not 54. The 6 
remarkable strength of the interaction scFv C2-54 thereby visualized not only accounted for the quick 7 
enrichment of the C2 clone during the panning process but also explained the mechanical resistance of 8 
the precursor phage-antibody particle to the physical stress of the procedure. 9 
 10 
3.2. Specificity of the scFv C2 - 54 interaction 11 
 12 
The tests above certified that the isolated scFv C2 antibody kept the high affinity for the target protein that 13 
was first detected in the corresponding Phab isolated from the panning protocol. However, they did not 14 
clarify the specificity of the interaction. This is because only two unrelated proteins were employed as 15 
controls in the ELISA and the SPR assays just discussed. Furthermore, since the plates or chips coated 16 
with the target protein probably display its amino acid sequences with various degrees of denaturation, 17 
the results of Fig. 4A do not clarify the physical form of the recognized epitope(s). To address this 18 
question, the purified scFv C2 antibody was tested in a Western blot assay in which a denaturing 19 
polyacrylamide-SDS gel was loaded with whole extracts of P. putida and E. coli. As shown in Fig. 4B, 20 
scFv C2 recognized specifically the 54 protein both purified and in the context of a whole cell extract. 21 
Such recognition included the homologous protein of E. coli, thereby suggesting that the antibody targets 22 
distinct antigenic regions shared to an extent by the two bacteria. Finally, that binding occurred in the 23 
denaturing gel system of Fig. 4B as well as in an ELISA plate was indicative that the antibody recognized 24 
its target site in 54 both as folded sequence (e. g. in the SPR assays and, to an extent in the ELISA test) 25 
and as a linear epitope. This means that at least one contiguous sequence of amino acids of 54 gives a 26 
good signal with the scFv C2 antibody. To identify such a segment of the primary structure of the sigma 27 
factor we run the epitope-mapping experiments described below.   28 
 29 
3.3. Identification of the 54 site targeted by scFv C2 30 
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 1 
A low-resolution map of the part of the 54 recognized by scFv C2 was drawn by examining the signals 2 
raised by a small collection of truncated polypeptides derived from the sigma factor in a Western blow 3 
assay. To this end, five DNA segments corresponding to protein fragments named F1 to F5 were 4 
amplified from the P. putida rpoN gene sequence and cloned into pET-vectors (Novagen) under the 5 
control of the T7 RNA polymerase promoter as explained in Materials and Methods (see Fig. 5A). 6 
Specifically, these fragments comprise amino acids Met1 to Ala324 (F1), Glu312 to Met497 (F2), Met1 to 7 
Arg238 (F3), Met1 to Leu221 (F4), and Met1 to Ser153 (F5) of the original 54 primary sequence of P. 8 
putida. The resulting plasmids (pET-F154 to pET-F554) incorporated a 6xhis-tag at the C-terminus of 9 
the respectively produced polypeptides. E. coli BL21/DE3 (pLysS) cells harbouring each of these pETs 10 
were induced with IPTG for overproduction of the cognate 54 fragments and the extracts were loaded in 11 
SDS-polyacrylamide gel. Each of the five truncated proteins could be made out with the naked eye upon 12 
staining the polyacrylamide gel with Comassie blue and could be unequivocally identified in the blotted 13 
gel was with a anti-6xhis MAb-POD conjugate (not shown). However, those proteins labelled F2 and F5 14 
failed to produce any signal when the same membrane was probed with purified scFv C2 in a Western 15 
assay (Fig. 5B). This was in contrast with the others (F1, F3 and F4), which were bound by the 16 
recombinant antibody as strongly as the full-length 54 protein used as control. This result grossly located 17 
the target epitope somewhere between amino acids Ser153 and Leu221 of the 54 primary sequence, a 18 
region that has been mapped as the RNA polymerase core binding determinant (Gallegos and Buck, 19 
1999; Wong et al., 1994).  20 
 21 
To delimit the amino acid sequence bound by scFv C2, overlapping deca-peptides and dodeca-peptides 22 
with either the native sequence of 54 between Ser153 and Leu221 or entered with various amino acid 23 
replacements (Fig. 5C) were synthesized and attached to cellulose membranes (Frank and Overwin, 1996; 24 
Reusch et al., 1994). As shown in Fig. 5C, the peptides having the sequence YLEDTLEEIC were strongly 25 
bound by scFv C2. This epitope spans amino acid positions 172-181 of the P. putida 54 sequence which is 26 
included in the larger region believed to interact directly with the RNA polymerase core (Gallegos and Buck, 27 
1999; Wong et al., 1994). Furthermore, the reactivity to scFv C2 displayed by the synthetic dodeca-peptides 28 
containing amino acid replacements through the YLEDTLEEICAG segment revealed that residues Tyr172, 29 
Asp175, and (to a lesser extent) Leu177 appeared to be essential for binding. None of the other 30 
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substitutions tested had such a dramatic effect (Fig. 5C). These results identified YLEDTLEEIC as the 1 
minimal polypeptide sequence that is recognized by scFv C2 within the larger structure of 54. Furthermore, 2 
the dot-blot tests of Fig. 5C pinpointed the 3 residues mentioned above that play a key role the interactions 3 
with the CDRs of scFv C2. As explained below, these data were instrumental to make sense of the surfaces 4 
of the two proteins that are involved in mutual recognition. 5 
 6 
3.4. A structural model for the interaction scFv C2 - 54 7 
 8 
That scFv C2 interacts strongly with the native 54 factor in the SPR assays and plausibly in the ELISA 9 
plates as well suggest that the targeted sequence had to be exposed on the protein surface. But also, since 10 
the factor is recognized as a linear, denatured polypeptide as well in a typical Western blot, chances are that 11 
the specific epitope may lack a significant secondary structure. These considerations provided a starting 12 
point for building a structural model of the entire scFv C2 - 54 complex or at least of its directly interacting 13 
surfaces. Although the specific 3D structure of scFv C2 was not determined, its similarity with many other 14 
scFvs which have been crystallized makes it easy to construct a highly reliable model of the linked VH-VL 15 
complex that shape the recombinant antibody. On the other hand, while the physical structure of the full-16 
length bacterial 54 factor has not been resolved yet, the organization of the segment comprising residues 17 
69-198 of the Aquifex aeolicus protein has been determined by NMR (Hong et al., 2009). Luckily, this 18 
protein sequence includes the positions equivalent to those found to bind 54 of P. putida identified above, 19 
what allows a trustworthy prediction of the corresponding structure. On this basis we set out to explore an 20 
optimal fitting between the two 3D partners by applying the HADDOCK software for flexible docking 21 
simulations (de Vries et al., 2010). Fig. 6 shows the most probable spatial interaction between the inferred 22 
structures of scFv C2 and the fragment A135 to N277 of 54 in which the relatively unstructured peptide 23 
YLEDTLEEICAG seems to dock exactly in the most variable region of the CDRs of the recombinant 24 
antibody. In this respect, although the data of Fig. 6 is basically a simulation, it does account for the 25 
flexibility of the scFv part to bind its target antigen either as a linear peptide or in the context of a structured 26 
protein. It has to be noted that the equivalent regions of the known 54 sequences of other bacteria (P. 27 
aeruginosa, P. syringae,  B. subtillis, E. coli, S. typhimurium, and V. cholerae, Fig. 7) are not fully conserved 28 
and therefore the scFv may be optimal only for the P. putida specimen. This does not rule out a degree of 29 
cross-reactivity with factors of related bacteria, as shown in Fig. 4B with the 54 of E. coli.  30 
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 1 
 3.5. Conclusion 2 
 3 
The results reported above illustrate the power of phage display for isolating super-binders to distinct 4 
transcriptional factors that may be produced at very low levels in bacterial cells. The diversity of 5 
antibodies stemming from the immune response of the inoculated animal allows setting up selection 6 
(panning) conditions for scFv variants with predefined characteristics. In the case of scFv C2, the 7 
recombinant antibody seems to both interact with its target site in the P. putida 54 protein both in the 8 
context of the native protein as well as part of a denatured polypeptide. One extra bonus of the procedure 9 
followed for isolation of scFv C2 is that one can produce large amounts of Phabs, ie. M13 capsides 10 
bearing apical scFv-pIII hybrids. These Phabs  behave as antibody-like particles able to attach the entire 11 
viral body to the antigen targeted by the scFv.  When Phab preparations are employed in Western blots, 12 
the proteins of interest can be revealed in the gel with an anti-M13-MAb-POD conjugate. Since the target 13 
of this reagent is the very abundant phage surface protein, there is a dramatic amplification of the 14 
corresponding signal that allows detection of just a few molecules in the sample. This approach has been 15 
employed successfully to count the number of 54 molecules per cell of P. putida growing under various 16 
conditions, which turns out to be ~80 ± 26 (Jurado et al., 2003). This figure is in the range of that found in 17 
E. coli (Ishihama, 2000) and barely above the number of 54-dependent promoters (Cases et al., 2003; 18 
Zhao et al., 2010). These relatively low figures are likely to make transcription of the cellular functions 19 
controlled by the factor adopting an stochastic behaviour (Raffaelle et al., 2005; Ghosh et al., 2010; Silva-20 
Rocha and de Lorenzo, 2010). Such a gene expression scenario in relevant promoters of P. putida and 21 
the TOL plasmid (Koutinas et al., 2010; Silva-Rocha et al., 2011) is currently under examination in our 22 
Laboratory.  23 
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 15 
LEGENDS TO FIGURES 16 
 17 
Fig. 1. Workflow for generation of scFv libraries binding the 54 factor of P. putida. The sketch 18 
summarizes the main steps of the process as described in McCafferty and Johnson (1996). Mice were 19 
inoculated with the purified protein and, after a period of time to allow an immune reaction, RNA was 20 
directly extracted from spleens. This was first retrotranscribed to DNA and the sequences corresponding 21 
to the VH and VL chains amplified separately with suitable primers. These PCR products were then 22 
assembled in vitro and captured in a phage display vector. The resulting library was then subject to 23 
various rounds of panning on microtiter plates coated with the same purified 54 factor used for 24 
inoculation. Those M13-scFv clones that were bound to the plates were then kept as candidates for 25 
further analysis.  26 
 27 
Fig. 2. Phabs binding the 54 factor of P. putida. (A) Enrichment of scFv-M13 particles upon successive 28 
panning rounds of the displayed VH-VH library on 54-coated microtiter plates. (B) Binding of Phabs C2, 29 
C23 and C47 and one unrelated Phab-MBP (used as a negative control; (Nissim et al., 1994)) to 54 or 30 
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ovalbumin (OVA) as determined by ELISA. Different dilutions of Phabs were incubated on microtiter 1 
plates coated with the indicated antigens. After washing with PBS, the bound Phab was developed using 2 
anti-M13-POD conjugate and the plates read at OD490. The data shown are relative to the maximal OD490 3 
obtained by Phab C2 at the higher titer employed (OD490~ 2.0).  4 
 5 
Fig. 3. Amino acid sequence of scFv C2. The primary sequence of the strong 54 binder named scFv C2 6 
encoded by phagemid pPC2 is shown. The positions of the N-terminal signal peptide, the VH domain, the 7 
(Gly4Ser)3 linker peptide, the VL domain, and the E-tag are indicated. The complementarity determining 8 
regions (CDR) of the VH and VL domains are labelled and underlined. The secretion signal and the motif 9 
recognized by the bacterial signal peptidase is shown. When produced in E. coli XL-1 Blue cells (supE) 10 
this scFv is synthesized as a hybrid with the apical protein p3 of phage M13. The location of the 11 
suppressible stop codon (amber), which is placed between the scFv and the p3 coding sequence is 12 
indicated. 13 
 14 
Fig. 4.  Specific binding of scFv C2 to 54.  (A) ELISA of purified scFv C2 and a negative control (scFv 15 
6AC3; Fernandez et al., 2000) to 54 and ovalbumin (OVA). Different dilutions of each of the scFvs were 16 
incubated on plates coated with the antigens indicated. After washing with PBS, the bound scFv was 17 
developed using anti-E-tag-MAb-POD conjugate and the plates were read at OD490. The data shown are 18 
relative to the maximal OD490 obtained by scFv C2 (OD490~ 2.0).  (B) Western blot with purified scFv C2  19 
made with the following samples. Lane 1 contains 1.25 ng of purified 54 of P. putida. Lanes 2-4 are 20 
loaded with total protein extracts prepared from P. putida , E. coli wild type, and E. coli rpoN cells, all 21 
harvested at stationary phase. ~ 1.25 x108 CFU were applied per lane. The scFv C2 and anti-E-tag- MAb-22 
POD were used for detection as described in the text. 23 
 24 
Fig. 5. Mapping of the 54 epitope recognized by scFv C2. (A) Five fragments derived from P. putida 54 25 
(F1: Met1-Ala324; F2: Glu312-Met497; F3: Met1-Arg238; F4: Met1-Leu221; F5: Met1-Ser153) were 26 
overproduced in E. coli BL21 (DE3) cells harbouring each of the pET-plasmids encoding them. (B) Whole-27 
cell protein extracts were prepared from these cells and subjected to Western blot using scFv C2 as the 28 
primary antibody and the anti-E-tag-MAb-POD conjugate for developing. As shown, purified 54 and 29 
fragments F1, F3 and F4 were detected, but F2 and F5 failed to give any signal. (C) Cellulose membranes 30 
22 
 
containing deca-peptides (top) spanning the 54 positions Ser153 to Leu221 were probed with scFv C2 and 1 
developed with the anti-E-tag-MAb-POD conjugate. Only the peptides spanning the sequence 2 
NGQGYLEDTLEEICAG (168-184) are shown. The lower membrane was spotted with mutant 3 
dodecapeptides bearing a collection of alanine-substituted derivatives and probed with scFv C2 as before. A 4 
permissive Ser181Cys change was entered in all peptides as a reference. Note the essentiality of residues 5 
Tyr172, Asp175 and to a lesser extent, Leu177 (marked with an asterisk).  6 
 7 
Fig. 6.  Tridimensional model of the most probable interactions between the two inferred 3D structures of 8 
scFv C2 and 54. scFv C2 is coloured grey with disulphide bridges in dark blue. Fragment A135 to N277 of 9 
54 is labelled with a green code. The mapped interacting region YLEDTLEEICAG (172-183) of 54 is 10 
marked in yellow. Note the apparent lack of significant secondary structure at that site. 11 
 12 
Fig. 7. Alignment of the epitope of the P. putida 54 protein recognized by scFv C2 with homologous regions 13 
of the factor in other bacteria. Note the conservation of the amino acids as represented with a color code. 14 
The residues more important for mutual recognition are marked with an asterisk at the bottom.  15 
 16 
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